欧洲药品管理局(emea)最近完成了有关非类固醇抗炎药(NSAID)吡罗昔康的安全性评价。
The European Medicines Agency (EMEA) has recently completed a review of the safety of the non-steroidal anti-inflammatory drug (NSAID) piroxicam.
因此建立适应药品管理的规范评价模式是再评价的重点，也是需要解决的难点。
Establishment of assessing model suitable to drug management is vital to settle post-marketing drugs.
因此建立适应药品管理的规范评价模式是再评价的重点，也是需要解决的难点。
Establishment of assessing model suitable to drug management is vital to settle post-marketing drugs.
应用推荐